Strategies and Challenges in Measuring Protein Abundance Using Stable Isotope Labeling and Tandem Mass Spectrometry by Kolbrun Kristjansdottir et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
11 
Strategies and Challenges in Measuring Protein 
Abundance Using Stable Isotope Labeling and 
Tandem Mass Spectrometry 
Kolbrun Kristjansdottir, Satoe Takahashi,  
Samuel L. Volchenboum and Stephen J. Kron 
The University of Chicago, Chicago, IL 
USA 
1. Introduction  
Mass spectrometry (MS) is a powerful method for identifying proteins, and modern mass 
spectrometers are capable of remarkable speed, resolution and sensitivity. A single tandem 
mass spectrometry experiment can now lead to the identification and quantitation of 
thousands of proteins down to sub-femtomolar concentrations. Tandem mass spectrometry 
experiments generally involve extraction of proteins from cells, biofluid, or tissue followed 
by digestion of proteins to peptides, separation of peptides on an HPLC, and direct injection 
into a mass spectrometer (LC-MS/MS). The mass spectrometer measures the mass of each 
peptide ion (MS1) and selected ions are fragmented (MS/MS or MS2). Mass and 
fragmentation spectra of each peptide are compared against predicted peptide 
fragmentation spectra from the known proteome by database search engines (reviewed in 
Aebersold and Mann 2003). LC-MS/MS instruments also record peptide ion intensities, 
offering the potential for direct measurement of peptide concentration and thereby protein 
abundance. However, the extent of ionization of peptides by electrospray ionization is 
dependent on peptide sequence and modification, elution conditions, complexity of the 
sample, and other factors. As a result, the absolute intensities of ions derived from non-
identical peptides cannot provide accurate or direct quantitation. Approaches such as 
peptide ion chromatogram extraction and spectral counting have been developed to obtain 
relative quantitation of protein abundance (Ono et al. 2006; Fischer et al. 2006; Tang et al. 
2006; Paoletti et al. 2006; Listgarten and Emili 2005; Wiener et al. 2004; Wang, Wu, Zeng, et 
al. 2006). Collectively termed “label-free” quantitation, these approaches require extensive 
analysis of reference samples and/or significant data redundancy, often requiring many 
hours of mass spectrometry time per sample. Although highly promising, label-free 
approaches remain impractical for users lacking access to dedicated mass spectrometry 
instrumentation and advanced informatic approaches. 
Stable isotope labeling provides an attractive alternative to label-free approaches. Stable 
isotopes are sufficiently stable to be non-radioactive. They have equal numbers of protons as 
their parental element but they differ in mass by the difference in the number of neutrons. 
Carbon, hydrogen, oxygen, nitrogen and sulfur have two or more isotopes with measurable 
abundance in Nature. For example, carbon is found as the predominant “light” isotope 12C 
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(98.89%), a stable “heavy” isotope of 13C (1.11%) and a radioactive “heavy” isotope of 14C 
(trace amounts) in Nature. Other stable isotopes relevant to protein mass spectrometry 
include Hydrogen 2H (0.02%), also called deuterium, Nitrogen 15N (0.37%), Oxygen 17O 
(0.04%) and 18O (0.02%), and Sulfur 33S (0.76%), 34S (4.29%), and 36S (0.02%). Carbon and 
nitrogen are the most common atoms in peptides resulting in 13C and 15N being the 
predominant isotopes present in all naturally occurring proteins, and to a lesser extent, 
oxygen and sulfur isotopes. As a result, instead of each tryptic peptide injected into the mass 
spectrometer having a single mass, each peptide is represented as a collection of different 
masses in proportions that reflect the natural abundance of the stable isotopes. This 
collection of masses present in the mass spectrum is termed the “isotopic envelope” of a 
peptide (Fig. 3). 
A stable isotope labeled peptide and its unlabeled counterpart have the same chemical 
formula and structure and thus nearly identical chemical properties, such that they are 
expected to elute together from reverse phase chromatography. Despite their similar 
chemical properties, the presence of the stable isotope facilitates independent assessment 
because of the mass difference. Combining the light (unlabeled) and heavy isotope labeled 
peptides in one sample allows for direct comparison of ion intensities. In principle, this 
offers highly accurate relative quantitation and avoids the need for significant data 
redundancy. With these and other advantages, stable isotope labeling would appear to 
satisfy the criteria for an ideal quantitative mass spectrometry strategy. However, challenges 
remain before stable isotope quantitation becomes a straightforward, robust, and reliable 
approach accessible both to non-experts and users of service laboratories. Here, we provide 
an up-to-date and critical review of stable isotope labeling methodologies, available 
software for data analysis, and emerging new applications of these powerful approaches. 
2. Absolute versus relative quantitation  
Stable isotope labeling can provide either absolute or relative quantitation. Absolute 
quantitation is obtained by comparing a known amount of added stable isotope labeled 
peptide and comparing directly with the unlabeled peptide counterpart, an expensive and 
laborious methodology for large proteomic studies. However, relative quantitation of 
proteins and peptides from complex samples can be performed by labeling the sample with 
stable isotope(s) and comparing to an unlabeled control. The levels are directly compared, 
providing a fold-change. Because the sample is compared to a control, changes due to the 
perturbation can be identified. Therefore, complex samples can be analyzed without any 
prior knowledge of the identity of peptides and proteins. 
2.1 Using stable isotopes to achieve absolute quantitation 
Stable isotopes can be incorporated into synthetic standards to obtain absolute quantitation. 
Isotope dilution and related approaches have been used in the small molecule field for 
decades (Baillie 1981). A known amount of stable isotope labeled analog of the compound of 
interest (internal standard) is spiked into a sample containing the unlabeled compound (Fig. 
1). The intensity of the unlabeled molecule is compared directly to the intensity of the stable 
isotope labeled molecule, and the peak ratio is calculated. For optimal performance, a 
standard curve is generated from a range of concentrations of the internal standard. Some of 
the earliest peptide- and protein-based applications of mass spectrometry for tracking and  
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Fig. 1. Methods for stable isotope labeling. Stable isotope labeling for relative quantitation 
can occur through metabolic, chemical and enzymatic methods. Metabolic labeling is 
performed during cell culture growth or by feeding or growing organisms such as yeast and 
flies in stable isotope labeled food or media. An example of metabolic labeling is SILAC. 
Chemical labeling is possible at the protein level with methods such as ICAT, HysTag and 
acrylamide labeling and at the peptide level with iTRAQ and TMT. Finally, enzymatic 
labeling is performed at the peptide level by trypsin catalyzed 18O labeling. Absolute 
quantitation involves spiking synthetic stable isotope labeled proteins or peptides (red 
arrows) into unlabeled samples.  
quantitation were the use of enzymatically labeled peptides generated via trypsin 18O-
exchange (Desiderio and Kai 1983), peptides synthesized using 13C, 2H-labeled amino acids 
(Barr et al. 1996), and 15N labeled peptide hormones (Kippen et al. 1997). To study pigments 
in the eye, a deuterium-containing peptide from rhodopsin was used as an internal peptide 
standard for determining the absolute amount present in rod outer segments (Barnidge et al. 
2003). Taken to its logical extreme, it would be feasible to spike a sample with one or more 
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heavy isotope labeled synthetic peptide reporters for every protein in the predicted 
proteome, a strategy known as Absolute Quantification (AQUA) (Gerber et al. 2003). This 
methodology can also be exploited to provide absolute quantitation of post-translational 
modifications.  
Synthesizing or expressing stable isotope labeled proteins can generate several peptide 
standards that can be used even in fractionated samples. In Protein Standard Absolute 
Quantification (PSAQ), stable isotope labeled proteins are synthesized in vitro and 
purified to homogeneity before being added to the proteomic sample (Brun et al. 2007; 
Dupuis et al. 2008). Internal protein standards can also be obtained by metabolic labeling 
of organisms, such as E. coli (Hanke et al. 2008). Additionally, a single synthesized 
concatemer protein comprised of peptides from 20 proteins of interest (QconCAT) has 
been generated to quantify a mixture of proteins (Pratt et al. 2006; Johnson et al. 2008; 
Rivers et al. 2007; Beynon et al. 2005). Taken together, these studies show that the absolute 
quantitation of peptides and proteins using mass spectrometry is feasible (Brun et al. 
2009). However, in order to synthesize or isolate the internal standard, the sequence and 
identity of the peptide or protein of interest must be known. The complexity of the sample 
is limited by practical considerations of obtaining sufficient numbers of internal standards 
for proteome coverage.  
2.2 Relative quantitation  
In contrast to absolute quantitation, relative quantitation requires no prior knowledge of the 
peptides and proteins. In a typical experiment, one sample is labeled with a stable 
isotope(s), while the other is left unlabeled. After perturbing or treating one of the samples, 
it is mixed with the untreated control and mass spectrometry analysis performed. Since the 
stable isotope does not change the chemical properties of the peptide, the intensities of the 
unlabeled and labeled ionized species can be directly compared and provide relative 
quantitation values between the samples. Although relative quantitation requires 
comparison to a control sample, it is not limited by sample complexity nor does it require 
prior knowledge of peptide identity. Because relative quantitation simply compares two (or 
more) samples, a wide range of stable isotope labeling methodologies can be used. 
3. Stable isotope labeling methodologies for relative quantitation 
Relative quantitation involves comparing unlabeled and labeled peptides or fragment ions. 
Quantitation can be performed at the MS1 or the MS2 level, depending on the nature of the 
stable isotope label. When labeling and quantitation occur at the MS1 level, the labeled 
sample is compared to an unlabeled (control) sample. Peptides are detected in the mass 
spectrometer as pairs, the heavy peptide shifted by the mass of the isotope(s). Comparison 
of light and heavy peptide peaks gives fold-difference or relative quantitation. For 
quantitation at the MS2 level, every sample, including the control, is labeled with an isobaric 
tag. The peptides co-elute and are undistinguishable at the MS1 level. However, 
fragmentation (MS2) of the peptide releases reporter ions that differ for each fraction and 
can be directly compared for relative quantitation. The method of labeling for MS1 level 
quantitation can occur via a metabolic, chemical or enzymatic process, but MS2 level 
quantitation is only feasible using chemical labeling. The method and timing of labeling is 
summarized in Fig. 1. Fig. 3 illustrates quantitation at MS1 and MS2 level.  
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3.1 Quantitation at the MS1 level 
3.1.1 Metabolic labeling  
Metabolic labeling for protein quantitation was demonstrated in yeast grown on commercial 
rich media derived from 15N-enriched algal hydrolysate. The relative abundances of 
phosphopeptides in the light and heavy samples were then determined by MALDI mass 
spectrometry (Oda et al. 1999). Analogous approaches have been applied to a number of 
organisms including worms and flies, culminating with the metabolic labeling of a rat, 
accomplished through feeding with 15N-enriched algae to produce tissue-specific internal 
standards for global quantitative proteomic analysis (Wu et al. 2004). While metabolic 
labeling with 15N is inexpensive and simple to perform, the distribution of isotopic forms for 
each peptide depends on the amino acid composition, complicating quantitative analysis 
and manual validation. 
Currently, the most widely used metabolic labeling approach for protein quantitation is 
stable isotope labeling with amino acids in cell culture (SILAC) (Ong, Kratchmarova, and 
Mann 2003; Ong et al. 2002; de Godoy et al. 2006; Amanchy et al. 2005). When cells are 
grown for several doublings in tissue culture with a stable isotope labeled form of an 
essential amino acid (e.g. lysine) as the sole source and at a small excess, this amino acid is 
incorporated into newly synthesized proteins until all are homogeneously labeled. Although 
any of the 20 naturally occurring amino acids could be used as a precursor for labeling, 
lysine, arginine and leucine are commonly used, with serine, glycine, histidine, methionine, 
valine, and tyrosine to a lesser extent (reviewed in (Beynon and Pratt 2005). The most 
common isotopes in SILAC are 13C and 15N, since they demonstrate less kinetic isotope 
effect than 2H and do not change the elution profiles of labeled peptides in reverse phase 
HPLC chromatography (Zhang and Regnier 2002; Zhang et al. 2001; Zhang et al. 2002).  
Trypsin is the most frequently used enzyme protease in proteomics, cleaving on the 
carboxyl-terminal side of lysine and arginine residues. Therefore, each non-C-terminal 
tryptic peptide is predicted to contain either a single carboxyl-terminal lysine or arginine. 
With a mass difference of 4 to 10 Da, due to labeling of the single terminal lysine or arginine, 
most pairs of peptides can be easily recognized by their offset envelopes of isotopic species 
(Fig. 3).  
The advantages of SILAC using lysine and arginine as the labeled amino acids include the 
ease of complete labeling and that every peptide is labeled, with the exception of the C-
terminal peptide. Although trypsin fails to cleave at some post-translationally modified 
lysine and arginine residues, this does not prevent quantitation. Stable isotope labeled 
amino acids (Cambridge Isotopes Laboratories) and several types of SILAC tissue culture 
media including DMEM, RPMI and IMEM (Thermo Scientific Pierce, Invitrogen) are 
commercially available.  
SILAC is limited to organisms that can be grown on defined media. While this is 
straightforward for cell lines, bacteria, and yeast cells, it precludes most whole animal and 
patient studies. Super-SILAC, a method for quantitative proteomics of human tissues was 
recently described (Geiger et al. 2010). Here, unlabeled tissue samples are mixed with SILAC 
labeled human cell lines (Super-SILAC mix) and relative quantitation is performed. 
Examining several tissue samples mixed with the same internal control, the Super-SILAC 
mix, allows for relative comparison between different tumor samples. Similarly, stable 
isotope labeled mouse tissue (Mouse Express) is available from Cambridge Isotope 
Laboratories and can be used in combination with unlabeled mouse tissue for relative 
quantitation.  
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Finally, SILAC experiments usually consist of two samples, a control (heavy) and treatment 
(light) or vice versa. However, increased availability of labeled amino acids, now allows for 
comparisons of three (Blagoev et al. 2004; Andersen et al. 2005) to five samples (Molina et al. 
2009).  
 
 
Fig. 2. Structure of 18O, ICAT and iTRAQ labeling reagents. The figure shows the structure 
of several stable isotope labeling reagents. In 18O labeling, tryptic preptides are incubated in 
H218O water and trypsin catalyzes an oxygen exchange reaction at the C-terminus of the 
peptide (two 18O molecules incorporated). The sample is then mixed with an unlabeled 
sample and quantitation performed. In ICAT, a thiol reactive group reacts with the cysteine 
amino acids attaching the ICAT reagent, which includes a linker and biotin tag. Two 
samples are labeled, one with an ICAT reagent with a light linker, the other with a heavy 
linker. Biotinylated peptides are purified via the biotin tag and quantitation is performed. 
Finally, in iTRAQ, four (or eight) samples are labeled with isobaric reagents, all weighting 
145 Da total but having different reporter and balance group. For example, a 114 Reporter 
and a 31 Da balance group or a 117 Da Reporter and 28 Da balance group all add up to 145 
Da. The four labeled samples are mixed and fragmented together. The Reporter group is 
released and quantitation is performed by comparing the 114, 115, 116 and 117 peaks.  
3.1.2 Chemical labeling 
3.1.2.1 Isotope-coded affinity tag (ICAT)  
One of the first commercialized stable isotope tagging reagents was isotope-coded affinity 
tag (ICAT) (Gygi et al. 1999). Since its introduction in 1999, the ICAT approach has been 
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widely used (Gygi et al. 1999; Griffin et al. 2002; Zhou et al. 2002), and ICAT reagents are 
commercially available from Applied Biosystems. In ICAT, a pair of light and heavy 
reagents targets cysteine residues, adding a linker and a biotin tag for affinity purification 
(Fig. 2). While the linker region of the heavy reagent contains stable isotopes, the light 
reagent does not. Proteins are denatured, reduced and then labeled with heavy or light 
reagents, mixed and digested. The biotinylated peptides are purified using avidin affinity 
reagents, allowing for stringent washing that minimizes background binding. The main 
advantage of this method is that it leads to the enrichment of peptides containing cysteines, 
which are relatively rare, thereby significantly reducing the complexity of the peptide 
mixture and increasing the dynamic range of mass spectrometry analysis. But because only 
peptides and proteins containing cysteines are identified, the overall proteome coverage is 
low, resulting in less accurate quantitation. Finally, ICAT is limited to comparing two 
samples. 
Several global quantitation experiments have been performed using the ICAT approach, 
such as a comparison of protein expression in yeast using ethanol or galactose as a carbon 
source (Gygi et al. 1999). Other ICAT studies include identification of proteins regulated by 
the Myc oncoprotein (Shiio et al. 2002) by comparing the protein expression patterns 
between myc-null and myc-expressing cells and identification of proteins regulated by 
interferon treatment in human liver cells (Yan et al. 2004). 
3.1.2.2 Other cysteine-targeted methods 
Several other methods have been developed for chemical labeling of cysteines, including 
HysTag (Olsen et al. 2004) and acrylamide labeling (Faca et al. 2006b). HysTag is a 10-mer 
derivatized peptide consisting of an affinity ligand (His6-tag), a tryptic cleavage site, an Ala-
9 residue that contains either four (D4) or no (D0) deuterium atoms, and a thiol-reactive 
group that targets cysteines. The HysTag peptide is preserved in Lys-C digestion of proteins 
and allows subsequent charge-based selection of cysteine-containing peptides. To remove 
the HysTag, subsequent tryptic digestion reduces the labeling group to a dipeptide, which 
does not hinder effective MS2 fragmentation (Olsen et al. 2004). HysTag has many of the 
same advantages and disadvantages as ICAT.  
Another method involves the alkylation of cysteines of intact proteins with acrylamide (Faca 
et al. 2006b). While cysteine alkylation with acrylamide via Michael addition is an undesired 
reaction that frequently occurs during polyacrylamide gel electrophoresis (Patterson 1994), 
several features make it a useful tagging approach for quantitative analysis with stable 
isotopes. First, because of its small size and hydrophilic nature, the acrylamide moiety does 
not introduce significant mass shift or charge changes in the protein and does not negatively 
affect protein solubility. Second, cysteine labeling is facile, allowing for complete labeling. 
Finally, the reagents are relatively inexpensive, making it practical to perform experiments 
starting with large amounts of protein as needed for extensive fractionation and in-depth 
analysis (Faca et al. 2006b). The acrylamide method does not include a cysteine peptide 
enrichment step. Since any peptide can be identified, protein coverage is increased, dynamic 
range is decreased. However, only cystein containing peptides are stable isotope labeled and 
can be quantified. protein coverage is increased, dynamic range decreased and quantitation 
is limited to cysteine containing peptides. A recent study used a combination of acrylamide 
label cysteines and succinic anhydride labeled lysines to increase the quantitative coverage 
(Wang et al. 2009). However, the mass shift is small (3 Da), resulting in frequent overlap 
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between the isotopic envelopes of light and heavy peptides complicating analysis. 
Acrylamide labeling has been used extensively to study the proteome of serum in cancerous 
and non-cancerous samples (Faca et al. 2006a; Pitteri et al. 2008).  
3.1.3 Enzymatic labeling - Trypsin-catalyzed 
18
O labeling 
An enzymatic method for stable isotope labeling, trypsin-catalyzed 18O labeling, involves 
the transfer of 18O from heavy water to the carboxyl terminal of peptides by an oxygen 
exchange reaction (Fig. 2) (Reynolds, Yao, and Fenselau 2002; Stewart, Thomson, and Figeys 
2001; Heller et al. 2003; Yao et al. 2001; Mirgorodskaya et al. 2000). Trypsin is the most 
frequently used enzyme, though Lys-C and Arg-C are also capable of catalyzing this 
reaction. As trypsin digestion is the most common method of sample preparation before 
mass spectrometry, incubation of peptides with trypsin in 18O-enriched water is a 
straightforward addition to the workflow. The samples are then mixed, and the 16O and 18O 
forms of each peptide elute together from the HPLC as pairs of ions, which are identical 
except for their carboxyl ends. Similar to SILAC and ICAT, the relative abundance of 
peptides can be inferred based on the relative intensity between the "light" 16O and "heavy" 
18O ions in the MS1 spectra. 
The reaction can proceed in the opposite direction, termed “back-exchange”, resulting in 
decreased labeling yields. Although 18O labeling is possible during digestion, a separate 
labeling exchange reaction after proteolysis is preferable, because it reduces the volume of 
H218O to be used, and the use of immobilized trypsin can minimize back-exchange (Yao et 
al. 2001). The overall advantages of protease-mediated 18O exchange are that essentially any 
sample can be labeled, no chemical changes are introduced to the peptides, and the work-
flow is simple and inexpensive. The disadvantages include that only 2 samples can be 
labeled and that samples must be kept separate throughout the lysis, enrichment and 
proteolysis steps, potentially introducing errors due to differences in sample handling. 
Another disadvantage is that labeling is not as reproducible as some chemical methods, as 
the exchange reaction is highly sequence specific, and relies heavily on the purity of the 
H218O, the labeling time, buffer and temperature and the amount and activity of trypsin 
used. Trypsin-catalyzed 18O labeling (Desiderio and Kai 1983; Heller et al. 2003) is a slow 
reaction and complete labeling is difficult to obtain.  
3.2 Quantitation at the MS2 level – Chemical labeling with isobaric tags 
The most common method for quantitation at the MS2 label is isobaric tags for relative and 
absolute quantitation (iTRAQ), developed by Pappin and colleagues (Ross et al. 2004). 
iTRAQ involves chemical labeling of amine groups on peptides. The iTRAQ reagent consists 
of a reporter group, a balance group and a reactive group that reacts with lysine side chains 
and N-terminal groups of peptides (Fig. 2). In the original 4-component version, the reporter 
group masses are 114, 115, 116 or 117 Da and the balance group masses are 31, 30, 29 or 28 
Da resulting in a combined mass of 145 Da for all four reagents. Briefly, a control and three 
treated samples are labeled individually with one of the four iTRAQ reagents and then 
combined. Each isobaric tag has the same minor effect on the elution properties of the 
peptide resulting in co-elution of the four versions of the peptide. The peptides are 
indistinguishable at the MS1 and are selected to fragment within a single MS2 scan. During 
collision-induced fragmentation (CID) or other similar fragmentation methods, in addition 
to the conventional fragmentation at peptide bonds needed for peptide identification, the 
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reporter group ions (114,115, 116 and 117 Da) also break away from the backbone peptides 
(Fig. 3). Relative quantitation for each of the treatment conditions being studied is obtained 
by comparing the intensities of the reporter group fragments. 4- and 8-component iTRAQ 
kits are available from Applied Biosystems.  
 
 
Fig. 3. Quantitation at MS1 and MS2 level. Upper panel illustrates quantitation at MS1 level 
as a result of labeling by SILAC or trypsin catalyzed 18O labeling. One sample is labeled 
with heavy isotope while the other is not labeled. The samples are mixed and in the MS1 
spectra each peptide is represented as a peptide pair with an unlabeled or “light” peptide 
(blue) and a labeled or “heavy” peptide (red). Each peptide can be subjected to 
fragmentation resulting in MS2 spectra with identical b-ions but y-ions are shifted by the 
weight of the heavy isotope (not shown). Lower panel illustrates labeling with iTRAQ 
reagents, which requires quantitation at MS2 level. In iTRAQ all samples are labeled, 
typically four or eight total. The samples are mixed and because the iTRAQ reagent is 
isobaric, the peptides all co-elute and overlap, resulting in a single peptide envelope 
(purple). The peptides are fragmented together and the MS2 spectra contains the 
conventional fragment ions that overlap for all peptides and also, unique reporter ions for 
each sample, which are used for quantitation (114, 115, 116, 117).  
Tandem Isobaric Mass Tag (TMT) kits with two or six components that work by a similar 
principle are available from Thermo Scientific (Thompson et al. 2003). Recently, Cystein-
Reactive TMT reagents (cys-TMT) became available from Thermo Scientific. These cys-TMT 
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reagents, like ICAT, target cysteines on proteins and allow for enrichment of cysteine 
containing peptides. As in iTRAQ and the conventional TMT, the reagents are isobaric and 
quantitation is performed at the MS2 level.   
Another type of isobaric method is Isobaric Peptide Termini Labeling (IPTL) (Koehler et al. 
2011; Koehler et al. 2009). In IPTL two non-isobaric reagents are used. In one sample, the C-
terminal lysine residues are labeled with 2-methoxy-4,5-dihydro-1H-imidazole (MDHI) 
followed by N-terminal derivatization with tetradeuterated succinic anhydride (SA-d4). In 
the second sample, the C-terminal lysines are labeled with tetradeuterated MDHI-d4 and the 
N-terminal derivatized with SA. Thus the peptides are isobaric, each peptide is 4 Da heavier 
than an unlabeled peptide, with the stable isotopes on the C-terminal in the first group and 
N-terminal in the second group of peptides. Quantitation is then performed directly on the 
fragment ions at the MS2 level. Each fragment ion will have a 4 Da heavier counterpart, with 
deuterated C-terminal or y-ions from the first set of peptides deuterated N-terminal ions or 
b-ions from the second set. In IPTL each fragment ions provides a quantitative value.  
Isobaric methods can be used to label any type of sample, including biofluids and tissue, 
and up to 8 samples/conditions can be compared concurrently. However, iTRAQ and TMT 
is limited to instruments that can provide good MS2 spectra in the 100-120 Da range, such as 
the QSTAR Quadrupole Time-of-Flight instrument (ABI). Pulsed Q dissociation (PQD) and 
higher energy C-trap dissociation (HCD) recently made it possible to detect the low mass 
isobaric tag reagent fragments on linear ion trap instruments including the LTQ-Orbitrap 
(Thermo Scientific) (Meany et al. 2007; Armenta, Hoeschele, and Lazar 2009; Kocher et al. 
2009). The disadvantages of this type of chemical labeling are the presence of potential side 
reactions, the extra steps required to remove excess reagents and derivatization byproducts 
resulting in difficulty in achieving complete labeling. The iTRAQ approach has been used 
for several large scale proteomic quantitative studies including time resolved monitoring of 
kinase reactions (Zhang et al. 2005), comparison of organelle proteomes (Yan, Hwang, and 
Aebersold 2008) and monitoring of protein expression changes as cancer cells acquire 
increasing metastatic potential (Ho et al. 2009). Combining quantitation with 
phosphoproteomics, Aebersold and colleagues (Pflieger et al. 2008) recently described an 
iTRAQ method to simultaneously identify components and phosphorylation sites of protein 
complexes.  
3.3 Considerations for designing stable isotope experiments 
Factors to consider when choosing which stable isotope to work with include price and 
increased complexity by chromatographic seperation of 2H (Ong, Kratchmarova, and Mann 
2003). The most commonly used isotopes are 15N, 13C, and, to a lesser extent, 2H and 18O. A 
critical component to stable isotope labeling using chemical, enzymatic, or metabolic 
methods is achieving complete labeling. In metabolic labeling approaches, such as SILAC, 
stable isotopes are incorporated into proteins as they are expressed making complete 
labeling easily attainable. However, use of the method is limited to cultured cells or 
organisms that can be grown in the presence of heavy isotope. It is worth the effort to spend 
time optimizing and testing a labeled sample before starting an experiment, especially for 
non-metabolic labeling methods to achieve high levels of labeling. Although calculations 
can be done to normalize samples to extent of labeling, downstream analysis will be greatly 
simplified if labeling is complete. Unfortunately, even with optimization to achieve 
stoichiometric labeling of the majority of peptides, each of the methods is subject to one or 
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more artifacts, resulting in a subset of peptides that display partial or unexpected labeling, 
thereby confounding analysis.  
The timing of labeling is important in any quantitative experiment. The earlier the label is 
introduced and the sample can be mixed for downstream analysis, the better. Metabolic 
labeling methods allow for mixing of samples immediately following cell growth and 
before any protein and peptide enrichment methods. Protein labeling reagents such as 
ICAT and acrylamide allow for intermediate timing of labeling. In peptide labeling 
methods, such as iTRAQ, TMT and trypsin catalyzed 18O labeling, the sample is not mixed 
until several steps including cell lysis, protein separation (if any) and digestion have been 
performed. This can lead to introduction of sample handling errors. However, these 
reagents also allow for labeling of samples that metabolic labeling reagents cannot, 
including a wide range of clinical samples such as urine and tissue. Thus selection of 
labeling method should take into account type of sample and enrichment methods. If the 
label is introduced at a late stage in sample preparation care should be taken to minimize 
any difference in sample handling.  
All of the abovementioned methods of labeling, except for isobaric tags, result in generation 
of peptide pairs at the MS1 level, where the light and heavy peptides are separated by a 
predictable number of mass units. This allows background peaks to be readily distinguished 
from “real” peptides insofar as the “real” peptides are represented by both light and heavy 
forms with a characteristic mass offset. If the mass difference is small, the natural isotope 
distribution of the light form will overlap with the monoisotopic peak of heavy form, 
frustrating quantitiation. Trypsin-mediated 18O exchange yields a 4 Da mass difference that 
leads to challenging quantitation of higher charged peptides and peptides over 20 residues, 
particularly if the labeling is incomplete. Indeed, incorporation of a single 18O is common, 
leading to a mass difference of only 2 Da. In turn, even though acrylamide labeling is 
typically complete, it offers as little as a 3 Da mass shift. Although it is possible to 
deconvolute such overlapping distributions and quantify the heavy and light peaks, this is a 
complex and iterative process, requires high quality data, and is tedious. Thus, most 
commercial labeling reagents including SILAC and ICAT are generated to have ≥ 4 Da mass 
difference and avoid this complication. In addition, because increased number of peptide 
species results in more complexity at the MS1 level and mass spectrometers are limited in 
MS2 fragment scan speed and number, this can result in fewer protein identifications, 
especially when more than two samples are analyzed together. 
For optimal quantitation, a standard calibration curve should be generated for each 
quantitative measurement, plotting the measured intensity against the amount of analyte. 
The limit of detection (LOD) or instrument detection limit (IDL) is the lowest amount of a 
substance that is distinguishable from background noise.  Since there are often many steps 
prior to mass spectrometry analysis, additional error is imposed on each measurement, and 
the method detection limit (MDL) accounts for these steps. The limit of quantitation (LOQ) 
is the point at which the mass spectrometer can distinguish between two different amounts 
of analyte. Ideally, measurements would be acquired along the linear dynamic range, the 
portion of the curve in which the intensity increases linearly with analyte concentration (Fig. 
4, in green). The boundaries of the linear range are defined as the lower limit of quantitation 
(LLOQ) and the upper limit of quantitation (ULOQ). When performing absolute 
quantitation of a single or few peptides or proteins, generating standard curves for each 
analyte is straightforward. For complex and/or relative quantitation experiments individual 
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standard curves are often not feasible. When validating quantitation from complex samples, 
one should consider that peptide measurements outside of the linear range may 
underestimate the change in abundance.  
 
 
Fig. 4. An example of a standard curve showing the limits of detection and quantitation. The 
lowest amount of a peptide that can be detected in a mass spectrometer is defined as the 
limit of detection (LOD). Although the intensity of a peptide is dependent on the amount 
(number of moles present), this relationship is only linear over a certain range. This is the 
optimal range for quantitative measurements (in green) and its boundaries are defined as 
the lower limit of quantitation (LLOQ) and the upper limit of quantitation (ULOQ).  
One of the most critical considerations for mass spectrometry analysis is the inclusion of 
replicate analyses and follow-up biological validation. Replicates allow the researcher to 
evaluate reproducibility in identification and quantitation and statistical significance of any 
identified proteome changes. Although technical replicates are helpful to identify variations 
due to mass spectrometry analysis, biological replicates should be performed for any 
proteomic experiment. The variations in sample handling, cell growth, labeling procedure 
can be high. This becomes vital in the case of clinical samples where biological variation can 
be very high. The exact number of replicates and statistical considerations vary between 
sample types, origin and type of experiment. An optimal experiment would involve 
consultation with a statistician before the experiment is started such that sufficient sample 
numbers and replicates can be included in the analysis.  
4. Data analysis tools and suggestions to improve data quality  
4.1 Quantitation software for MS1 level data 
Selection of quantitation software depends on several factors including the stable isotope 
labeling method, the level of quantitation (MS1 versus MS2), the type of instrument used to 
obtain the data (ion traps versus Q-TOFs) and the availability of software (commercial 
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versus open source) (Table 1). Additional problems arise when the stable isotope label 
results in a mass shift small enough to allow overlap of the resulting isotopic envelopes, but 
specialized software is available to compensate for this overlap.  
Mass spectrometry manufacturers often provide proprietary software solutions for 
quantitation. Examples include Bioworks (Thermo Scientific), Peakpicker (Applied 
Biosystems) and WARP-LC™ 1.1 (Bruker). A large number of open-source software tools 
are available including AYUMS (Saito et al. 2007), ProRata (Pan et al. 2006), Mascot File 
Parsing and Quantification (MFPaQ) (Bouyssie et al. 2007), QUIL (Wang, Wu, Pisitkun, et al. 
2006), MSQuant (Mortensen et al. 2010) and Uniquant (Huang et al. 2011). Compilations of 
software are available including Trans Proteomic Pipeline (TPP) developed at the Institute 
for Systems Biology (ISB) in Seattle (reviewed in (Deutsch et al. 2010). Modules for 
quantitation include XPRESS (Han et al. 2001) and ASAPratio (Li et al. 2003). The ISB tools 
have been incorporated into Computational Proteomics Analysis System (CPAS), a suite of 
database and analysis tools for managing proteomics based experimental workflows and 
integrating database search algorithms (Rauch et al. 2006). CPAS was originally developed 
in the Fred Hutchinson Cancer Research Center but is now distributed as part of Labkey 
Server, an open-source project managed by the Labkey Software Foundation. Another open-
source integrated suite of algorithms, termed MaxQuant, was developed by Matthias 
Mann’s group and was specifically developed for quantitation of high-resolution MS data 
(Cox and Mann 2008).  
Separate software packages have been developed to account for the difficulties in 
interpreting spectra from isotopically labeled samples. An algorithm called regression 
analysis applied to mass spectrometry (RAAMS) corrects for partial 18O labeling as well as 
incorporation of naturally occurring isotopes (Mason et al. 2007).  
4.2 Quantitation software for MS2 level (isobaric) data 
Quantitation software for isobaric tags include commercially available solutions such as 
ProteinPilot and ProQuant from Applied Biosystems, Spectrum Mill from Agilent, Proteome 
Discoverer from Thermo Scientific and Scaffold Q+ from Proteome Software (Table 1). 
Open-source software includes Libra, a software module used within the Trans Proteomic 
Pipeline (TPP), MassMatrix, a search engine that performs quantitation of TMT and iTRAQ 
(Warren et al. 2010), IsobariQ which was designed for IPTL, iTRAQ and TMT (Arntzen et al. 
2011) and jTraqX, a platform independent tool for isobaric tag quantitation (Muth et al. 
2010). COMPASS is an integrated suite of pre- and post-search proteomics software tools 
specific to the OMSSA database search engine (Wenger et al. 2011).  
4.3 Common concerns and how to achieve high quality quantitation 
Despite the available software packages for peptide and protein identification and 
quantitation, manual validation is often required for confirmation. Inaccurate or ambiguous 
results are common when too few peptides can be quantified from a protein or where the 
standard deviation or p-value between multiple quantified peptides from a protein is not 
statistically significant. High-abundance proteins that yield ratios close to 1:1 have the 
highest confidence levels but provide little or no biological insight. As with any mass 
spectrometry experiment, low-abundance proteins are difficult to study because of the 
limited dynamic range. In addition, if the sample is too complex (too many peptides are in 
the sample), overlapping peptide spectra can occur and bring about errors in peptide  
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 Type Software Reference 
MS1    
 Commercial Bioworks Thermo Scientific 
 Commercial Peakpicker Applied Biosystems 
 Commercial Proteinscape 2 Bruker 
 Open source AYUMS Saito et al. 2007 
 Open source ProRata Pan et al. 2006 
 Open source TPP –XPRESS and 
ASAP Ratio 
Han et al. 2001; Li et al. 2003 
 Open source MaxQuant Cox and Mann 2008 
 Open source MSQuant Mortensen et al. 2010 
 Open source Quil Wang, Wu, Pisitkun, et al. 2006 
 Open source RAAMS Mason et al. 2007 
 Open source Uniquant Huang et al. 2011 
 Open source MFPAQ Bouyssie et al. 2007 
MS2    
 Commercial Proteome Discoverer Thermo Scientific 
 Commercial Scaffold Q+ Proteome software 
 Commercial ProteinPilot and 
ProQuant 
Applied Biosystems 
 Commercial Spectrum Mill Agilent 
 Commercial Proteinscape 2 Bruker 
 Open source TPP- Libra  
 Open source IsobariQ Arntzen et al. 2011 
 Open source MassMatrix Warren et al. 2010 
 Open source jTraqX Muth et al. 2010 
 Open source COMPASS Wenger et al. 2011 
Table 1. A list of currently available software tools for quantitation with stable isotopes. 
Quantitation software is organized by the level of quantitation (MS1 versus MS2), type of 
software (Commercial or Open source), name of software and reference(s) listed. 
quantitation both in MS1 and MS2. MS2 quantitation is currently much more sensitive to 
overlapping spectra than MS1 level quantitation methods. This is due to the large (>1 Da) 
selection window for peptide fragmentation at the MS2 level to obtain sufficient peptide 
signal. In iTRAQ and TMT, multiple co-fragmenting peptides can significantly alter the 
peptide ratio and because the reporter ions are cleaved they cannot be assigned to their 
originating peptides. Since fragment ions are used for quantitation in the IPTL method, this 
is likely to be less of an issue. Performing peptide and/or protein separations using 
immunoenrichment methods, chromatography, electrophoresis or by isolating cellular 
compartments can reduce sample complexity, improve quantitation at both the MS1 and 
MS2 level and increase detection of low abundance peptides. However, any fractionation 
method results in some sample loss and thus often requires more starting material. It is 
important to consider the smallest proteome subset appropriate for analysis. Since the mass 
spectrometer and reverse phase columns have limited loading capacity, reducing the sample 
complexity may improve both proteome coverage and the confidence of peptide 
identification and quantitation.  
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Accurate quantitation requires consideration of naturally occurring isotopes present in 
peptides, especially when small differences are measured using 13C stable isotopes. For MS1 
labeling, calculating the peptide ratio using the whole isotopic envelope is more accurate 
than performing quantitation on only the monoisotopic peak. For a given peptide sequence, 
the isotopic envelope can be calculated and correlated to the measured distribution, and the 
isotope enrichment can be measured. An overall enrichment correlation factor can ensure 
consistent metabolic labeling. This calculation needs to be performed for each quantitative 
measurement when using trypsin catalyzed 18O labeling, which can vary with peptide 
sequence. This algorithm has been incorporated into quantitative software. RAAMS uses a 
method to estimate the isotopic envelope based on “averagine”, the isotopic distribution in 
an average amino acid (C4.9384H7.7583N1.3577O1.4773S0.0417) (Mason et al. 2007). In MS2 level 
quantitation, including iTRAQ, TMT and IPTL, quantitative measurements cannot be 
determined over the elution time of a peptide, only for single fragmentation spectra. 
Instead, replicate measurement should be performed to increase confidence in quantitation. 
Finally, for both MS1 and MS2 labeling, the measurements are performed at the peptide 
level and not protein level. Proteins are inferred from peptides. The peptide ratios from 
what appears to be a single protein can differ for several reasons including that peptides can 
be identical in several proteins and that peptides could be post-translationally modified and 
not visible in the mass spectrometry data. Thus the protein value is a weighted average of 
all protein forms and not a single protein ratio. 
5. Harnessing the information obtained from stable isotope labeling  
With the exception of isobaric methods, the MS1 spectra will contain isotopic peptide pairs 
consisting of an unlabeled and a labeled peptide. Optimally, the mass spectrometer would 
recognize these pairs and preferentially select only "light" monoisotopic ions of pairs for 
fragmentation, thereby avoiding background and/or contaminating ions and offsetting the 
added complexity in the sample. This is particularly important for the analysis of complex 
stable isotope labeled samples where the number of peptide pairs far exceeds the number of 
possible fragmentation scans. In principle, the existing user-defined, data-dependent 
scanning software provided on commercial mass spectrometers can be adapted to direct the 
mass spectrometer to flag ions that are separated by a pre-defined mass and subject only 
these to fragmentation. For example, such a setting is called “mass tag” in Xcalibur software 
for Orbitraps and FT-ICR mass spectrometers (Thermo Scientific). However, as of the 
writing of this review, "mass tag" remains to be fully implemented. 
5.1 Other uses for stable isotope labeling 
Stable isotope labeling has been used to distinguish contaminants from bona fide interactors 
in immunopurifications (I-DIRT) (Tackett et al. 2005). Yeast cells containing an affinity-
tagged protein were grown in light SILAC media and control yeast cells in heavy media. 
After isolation of the affinity tagged protein complex, specific protein interactions were 
identified by mass spectrometry as a single unlabeled peptide (light), but background 
contaminant proteins present in both the control (heavy) and affinity-tag protein expressing 
cells (light) were identified as peptide pairs. Another clever use of stable isotope 
quantitation is to examine dynamic protein-protein complexes and protein-DNA complexes 
(Pflieger et al. 2008; Mittler, Butter, and Mann 2009) by combining affinity purification 
approaches with stable isotope tagging. Quantification of component stoichiometry of 
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multiprotein complexes has also been performed using a peptide-concatenated standard 
(PCS) strategy (Kito et al. 2007). In this strategy, tryptic peptides suitable for quantification 
are selected from each component of the multiprotein complex and concatenated into a 
single synthetic protein, resulting in equimolar amounts of each "heavy" reference peptide. 
Other uses for stable isotope labeling include measuring the rate of protein turnover (Pratt 
et al. 2002) and identifying phosphorylation sites (Pflieger et al. 2008).  
5.2 Use of stable isotopes to obtain faster and more accurate protein identification  
A complementary advantage of stable isotope labeling is that when both heavy and light 
forms are subjected to fragmentation, mass shifts are observed in the MS2 spectra that 
facilitate deconvolution and peptide sequence analysis. When only the carboxyl terminus is 
labeled as in lysine/arginine SILAC or 18O labeling, comparing the two fragmentation 
patterns reveals ions that derive from the carboxyl terminus (y-type ions) as those display 
characteristic mass shifts (e.g. 8 or  4 Da). Accordingly, comparison of spectra of labeled and 
unlabeled peptide fragments allows for assignment of peaks as shifting or non-shifting, 
facilitating de novo peptide sequence analysis (Hunt et al. 1986; Schnolzer, Jedrzejewski, and 
Lehmann 1996; Takao et al. 1991; Gray, Wojcik, and Futrell 1970; Rose et al. 1983). Peak 
assignment for validation of peptide identifications obtained by database search has been 
automated in the Validator software suite (Volchenboum et al. 2009), which recognizes 
isotopic peptide pairs from searched MS data and compares their identifications and 
fragmentation patterns. Because database search algorithms do not utilize the embedded 
information from comparison of labeled and unlabeled peptides, Validator software 
provides a direct and independent means to validate peptide identifications from database 
search algorithms.  
6. Conclusions 
Stable isotopes have become a versatile and useful tool in quantitative mass spectrometry. 
This review has described chemical, enzymatic and metabolic stable isotope labeling 
techniques while highlighting the advantages and disadvantages of each method. A wide 
variety of sample types can be labeled and analyzed from single proteins and complexes to 
bacteria, yeast, mammalian cells, biofluids and tissues. For optimal absolute quantitation, 
each peptide to be measured requires a labeled counterpart, making it a costly and laborious 
methodology for large proteomic studies. Complex samples are better suited to relative 
quantitation where fold-change is calculated by comparing peptide levels to a fully labeled 
control sample. Stable isotope labeling is also useful for identifying components and 
measuring the stoichiometry of protein-protein and protein-DNA complexes. Stable isotopes 
can also facilitate identification of posttranslational modifications and background 
contamination and to aid in peptide identification and validation. 
The advent of modern mass spectrometers has allowed for precise quantitation of sub-
femtomolar samples with their remarkable sensitivity, resolution, reproducibility and speed. 
However, many challenges remain, affecting the quality of results and resulting in pitfalls 
for experienced and naïve users alike. No isotopic method is free of the wide range of 
artifacts that arise due to biological variation, human error, design and implementation of 
instrumentation control and poorly written and implemented data analysis software. 
Confounding the situation, proteomics experiments provide spurious answers side-by-side 
with highly reliable results, often with no clear distinction among them. 
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Nonetheless, some common principles apply that will enhance the quality of every 
experiment. Achieving the most complete and consistent labeling feasible greatly simplifies 
downstream data analysis. Decreasing sample complexity to improve peptide statistics for 
each protein facilitates high confidence in identifications and the ready discovery of 
quantitation artifacts. Despite advantages in software design, manual validation through 
visual inspection of mass spectrometry spectra remains a critical step. Therefore, stable 
isotope labeling for protein quantitation by mass spectrometry is still an emerging 
technology and care must be taken to use appropriate controls, including biological and/or 
technical replicates, in order to identify potential problems with labeling, sample handling 
and/or data analysis. 
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